SeaStar Medical (ICU) Stock Price, News & Analysis

Company Overview

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Key Stats

• Today's Range: $1.18 to $1.27
• 50-Day Range: $1.15 to $1.39
• 52-Week Range: $1.11 to $13.85
• Volume: 149,368 shs
• Average Volume: 266,170 shs
• Market Capitalization: $13.15 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ICU Stock Analysis - Frequently Asked Questions

How have ICU shares performed this year?

SeaStar Medical's stock was trading at $1.94 at the beginning of the year. Since then, ICU shares have decreased by 34.5% and is now trading at $1.27.
View the best growth stocks for 2025 here.

How were SeaStar Medical's earnings last quarter?

SeaStar Medical Holding Co. (NASDAQ:ICU) issued its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.44) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.52) by $0.08. The firm earned $0.29 million during the quarter, compared to the consensus estimate of $0.15 million.
Read the conference call transcript.

When did SeaStar Medical's stock split?

SeaStar Medical's stock reverse split before market open on Monday, June 10th 2024. The 1-25 reverse split was announced on Monday, June 10th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Who are SeaStar Medical's major shareholders?

Top institutional investors of SeaStar Medical include Armistice Capital LLC (6.26%) and Tyche Wealth Partners LLC (0.43%). Insiders that own company stock include Kevin Chung, Jennifer A Baird, Heel Kenneth Van and Richard D Russell.
View institutional ownership trends.

How do I buy shares of SeaStar Medical?

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SeaStar Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 6/07/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ICU
• CIK: 1831868
• Web: seastarmedical.com
• Phone: 844-427-8100
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.47)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$26.23 million
• Net Margins: N/A
• Pretax Margin: -43,926.47%
• Return on Equity: N/A
• Return on Assets: -627.49%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.54
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $428 thousand
• Price / Sales: 30.73
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($6.29) per share
• Price / Book: -0.20

Miscellaneous

• Outstanding Shares: 10,355,000
• Free Float: 4,369,000
• Market Cap: $13.15 million
• Optionable: Not Optionable
• Beta: -0.89